Opioids and Workers’ Compensation in Colorado, Pinnacol Assurance Presentation
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 22, 2017, meeting.
First Regular Session | 75th General Assembly
Colorado General AssemblyPresented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 22, 2017, meeting.
This issue brief provides information on electric utilities in Colorado, and how utilities generate and distribute electricity to Colorado homes and businesses. The issue brief also describes the regulation of investor-owned electric utilities by the Public Utilities Commission (PUC).
The Colorado Health Insurance Exchange Oversight Committee was created pursuant to Article 22 of Title 10, Colorado Revised Statutes. The purpose of this committee is to guide Colorado's health insurance exchange, including reviewing the financial and operational plans of the exchange and...
During the 2017 legislative session, the General Assembly considered measures on environmental matters, public health care issues, and certificates and licenses. The bills and resolutions described below passed and became law, unless otherwise noted.
During the 2017 legislative session, the General Assembly considered several measures related to Medicaid, insurance carriers, and substance use disorder in Colorado. The General Assembly also considered measures related to background checks for some types of providers and made changes to the...
During the 2017 legislative session, the General Assembly considered measures related to tax credits, employee-owned businesses, the state’s sales and use tax structure, and reducing the regulatory burden on small businesses.
Final Report to the Colorado General Assembly by the Opioid and Other Substance Use Disorders Interim Study Committee.
This memorandum provides an overview of broadband internet service programs in Colorado, including the Colorado High Cost Support Mechanism; state grant programs and other state efforts; local governments’ ability to provide broadband; and related recent legislation.
This memorandum addresses patient access to experimental treatments, including access to clinical trials, participation in the U.S. Food and Drug Administration’s Expanded Access (Compassionate Use) Program, and access to treatments under Colorado’s Right to Try Act. Additionally, this...
The effective date for bills enacted without a safety clause is August 6, 2025, if the General Assembly adjourns sine die on May 7, 2025 (unless otherwise specified). Details
Request for Proposal for the COL study. Details
Our website is currently undergoing a redesign in order to provide a better experience for everyone. View the Beta site